Cover Image for BioPhoT seminar: From Hit Compound to Clinical Trials

Presented by

Tech Transfer & Commercialisation Events – Workshops, networking & expert insights to accelerate biomedical innovation. Stay informed and connected with Latvian Institute of Organic Synthesis!

Hosted By

11 Going

BioPhoT seminar: From Hit Compound to Clinical Trials

Name: BioPhoT seminar: From Hit Compound to Clinical Trials
Start: 2025-05-21T10:00:00.000+03:00
End: 2025-05-21T12:00:00.000+03:00
Location: Register to See Address

LIOS Innovation Hub

Register to See Address

Approval Required

Your registration is subject to approval by the host.

Welcome! To join the event, please register below.

You will be asked to verify token ownership with your wallet.

About Event

Join us for a special knowledge and experience sharing event focused on commercialisation of drug discovery projects.

Lector: Dr. Scott L. Dax
With 25+ years of experience in pharmaceutical R&D leadership, Dr. Dax has held senior roles within large pharma (Johnson & Johnson) and biotech firms. He was Chief Scientific Officer at CerSci Therapeutics, which was acquired by Acadia Pharmaceuticals in 2020.

Event Program:

09:50 – 10:00 Arrival

10:00 – 10:05 Introduction

10:05– 10:50 Keynote by Scott L. Dax

10:50 – 11:25 Fireside discussion and Q&A

11:25 – 12:00+ Networking and discussions

Event is funded by Long-term State Research Program project BioPhoT-research platform for innovative products in biomedicine and photonics (IVPP-EM-Inovācija-2024/1-0002)

Location

Please register to see the exact location of this event.

Presented by

LIOS Innovation Hub

Tech Transfer & Commercialisation Events – Workshops, networking & expert insights to accelerate biomedical innovation. Stay informed and connected with Latvian Institute of Organic Synthesis!

Hosted By

11 Going